Abstract:ObjectiveTo realize the detection and drug resistance of βlactamaseproducing Staphylococcus isolated from clinical specimens in a hospital, so as to provide reference for preventing and treating Staphylococcus infection.MethodsClinical and laboratory data of 1 725 βlactamaseproducing Staphylococcus isolated from clinical sepcimens between 2005 and 2010 were analyzed retrospectively.ResultsThe total detection rate of βlactamaseproducing Staphylococcus was 94.83% (1 725/1 819). The detection rate of each year was 88.68%(94/106), 89.69%(174/194), 91.72%(155/169),97.58%(242/248),96.10%(591/615) and 96.30%(469/487) respectively,there was an increased tendency(χ2=51.11, P<0.01; The detection rate of βlactamase was the highest in Staphylococcus sciuri(99.50%,198/199) and the lowest in Staphylococcus auricularis (80.37%,86/107)(χ2=58.08,P<0.01). Antimicrobial susceptibility testing results showed that βlactamaseproducing Staphylococcus isolates were sensitive to vancomycin, linezolid, furantoin and rifampicin, but were highly and multiply resistant to penicillin, ampicillin, ampicillin/sulbactam, oxacillin, cefazolin, ciprofloxacin, tetracycline, clindamycin, erythromycin, gentamicin and sulfamethoxazole/trimethoprim, the resistant rate was between 51.74% and 100.00%, and resistant rate of βlactamaseproducing Staphylococcus was higher than nonβlactamaseproducing Staphylococcus (χ2=7.00-485.39. P<0.01). 72.86% of βlactamaseproducing Staphylococcus aureus and 78.30% of βlactamaseproducing coagulase negative Staphylococcus were oxacillinresistant strains.ConclusionThe high detection rate and high drug resistant rate of βlactamaseproducing Staphylococcus is serious, it is necessary to intensify the monitor and stop quick increase of βlactamase producing Staphylococcus.